Hemolytic and uremic syndrome as a complication of long-term therapy with gemcitabine;Syndrome hémolytique et urémique compliquant un traitement au long cours par gemcitabine. À propos d'un cas, revue de la littérature

Revue de Medecine Interne

Volumn 23, Issue 2, 2002, Pages 189-192

  Dilhuydy, M S ^a   Delclaux, C ^a,c   Pariente, A ^b   De Precigout, V ^a   Aparicio, M ^a  

^a HÔPITAL PELLEGRIN   (France)

^b CENTRE HOSPITALIER DE PAU   (France)

^c Hopital Robert Boulin   (France)

Author keywords

Acute renal failure; Anemia; Gemcitabine; Haemolytic and uremic syndrome; Thrombotic microangiopathy

Indexed keywords

GEMCITABINE; HAPTOGLOBIN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; BONE MARROW SUPPRESSION; CASE REPORT; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; KIDNEY DISEASE; LONG TERM CARE; MALE; METASTASIS; PANCREAS ADENOCARCINOMA; RETICULOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; URINALYSIS;

EID: 0036170978     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(01)00535-5     Document Type: Article

References (16)

1. Acute renal failure due to haemolytic uraemic syndrome in adult patients
2. Cancer associated haemolytic uraemic syndrome: Analysis of 85 cases from a national registry
3. Safety profile of gemcitabine
4. Gemcitabine safety overview
5. Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine
6. A review of haemolytic uraemic syndrome in patients treated with gemcitabine therapy
7. Elevated reticulocyte count - A clue to the diagnosis of haemolytic uraemic syndrome associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: A case report
8. Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy
9. Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine
10. Myopathie ischémique sévère en territoire irradié après traitement par la gemcitabine
11. Microangiopathic hemolytic anemia: The possible role of vascular lesions in pathogenesis
12. Microangiopathic haemolytic anemia and mucinforming adenocarcinoma
13. Anémies hémolytiques extracorpusculaires non immunologiques
14. Microangiopathic hemolytic anemia and cancer: A review
15. Microangiopathic hemolytic anemia and experimental tumour-cell emboli
16. Mitomycin C related hemolytic syndrome in cancer patients